Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Yiannakou, Yan
Bouchoucha, Michel
Schiefke, Ingolf
Piessevaux, Hubert
Filip, Rafal
Stephenson, David
Green, Alexandra
Levine, Amy
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
929g
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [41] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
  • [42] Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trial
    Xiao, Ying Lian
    Dai, Ning
    He, Shui Xiang
    Tian, De An
    Liu, Si De
    Tian, Zi Bin
    Wang, Xiao Yan
    Li, Yan Qing
    Hou, Xiao Hua
    Fang, Xiu Cai
    Wen, Zhi Li
    Zeng, Wei Zheng
    Xu, Hong
    Sun, Ming Jun
    Liu, Yu Lan
    Wu, Yong Dong
    Shen, Xi Zhong
    Liu, Xiao Wei
    Liu, De Liang
    Chen, Min Hu
    JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (11) : 622 - 629
  • [43] A double-blind, placebo-controlled evaluation of safety and efficacy of 12-week, twice-daily treatment with prucalopride in patients with chronic constipation.
    Otten, MH
    Schneider, H
    Wurzer, H
    Tefera, S
    Van Eeghem, P
    Graf, W
    Van't Klooster
    GASTROENTEROLOGY, 1999, 116 (04) : A1055 - A1055
  • [44] Efficacy and Safety of Tenapanor in Patients With Constipation Predominant Irritable Bowel Syndrome: A 12-week, Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial
    Chey, William D.
    Lembo, Anthony J.
    Korner, Paul
    Yan, Andrew
    Rosenbaum, David P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S226 - S227
  • [45] Alicaforsen Enema in Chronic Pouchitis: Results of a Phase 3 Randomized, Double-blind, Placebo-controlled Trial
    Feagan, Brian
    Lindsay, James
    Rogler, Gerhard
    Moran, Gordon
    Varawalla, Nermeen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S364 - S364
  • [46] Breakthroughs in andrology: Vardenatil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial
    Hellstrom, WJG
    Gittelman, M
    Karlin, G
    Segerson, T
    Thibonnier, M
    Taylor, T
    Padma-Nathan, H
    JOURNAL OF ANDROLOGY, 2002, 23 (06): : 763 - 771
  • [47] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
    Biton, V
    Rosenfeld, W
    Schachter, S
    Perdomo, C
    Arroyo, S
    ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
  • [48] Efficacy and Safety of Vilazodone in Generalized Anxiety Disorder: A Randomized, Double-blind, Placebo-controlled Trial
    Thase, Michael E.
    Mathews, Maju
    Forero, Giovanna
    Nunez, Rene
    Chen, Changzheng
    Gommoll, Carl
    Durgam, Suresh
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S344 - S344
  • [49] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Ying Zhao
    Yuan-Yuan Yang
    Bao-Lin Yang
    Ya-Wei Du
    Da-Wei Ren
    Hong-Mei Zhou
    Jing Wang
    Hui-Min Yang
    Yao-Xian Wang
    Ying-Ying Zhang
    Sheng-Xian Wu
    Trials, 22
  • [50] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Zhao, Ying
    Yang, Yuan-Yuan
    Yang, Bao-Lin
    Du, Ya-Wei
    Ren, Da-Wei
    Zhou, Hong-Mei
    Wang, Jing
    Yang, Hui-Min
    Wang, Yao-Xian
    Zhang, Ying-Ying
    Wu, Sheng-Xian
    TRIALS, 2021, 22 (01)
12345